Skip to content

Drug interactions

Baricitinib + Natalizumab

Severity: Major

Baricitinib and Natalizumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Natalizumab impairs lymphocyte entry into tissues including the CNS and is linked to progressive multifocal leukoencephalopathy. Baricitinib is a JAK inhibitor that adds broad immunosuppression, increasing the risk of serious and opportunistic infections.

What this interaction means in plain words

Baricitinib and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Baricitinib belongs to Musculoskeletal; Natalizumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression through integrin blockade and JAK inhibition.

What to do

Avoid the combination. Choose one agent, and monitor for infection and new neurological symptoms if overlap cannot be avoided.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Baricitinib and Natalizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Baricitinib with Natalizumab?

MediHelp rates the interaction as major. Baricitinib and Natalizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Natalizumab impairs lymphocyte entry into tissues including the CNS and is linked to progressive multifocal leukoencephalopathy. Baricitinib is a JAK inhibitor that adds broad immunosuppression, increasing the risk of serious and opportunistic infections.

How serious is the interaction between Baricitinib and Natalizumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. Choose one agent, and monitor for infection and new neurological symptoms if overlap cannot be avoided.

What other medicines interact with Natalizumab?

MediHelp also lists interactions of Natalizumab with, for example, Vedolizumab, Axicabtagene ciloleucel, Belatacept. The full list is on the Natalizumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in